Cargando…

Factors associated with use and non-use of the Fecal Immunochemical Test (FIT) kit for Colorectal Cancer Screening in Response to a 2012 outreach screening program: a survey study

BACKGROUND: The one-sample fecal immunochemical test (FIT) is gaining popularity for colorectal cancer (CRC) screening of average-risk people. However, uptake and annual use remain suboptimal. METHODS: In 2013, we mailed questionnaires to three groups of nonHispanic White, Black, and Latino Kaiser P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gordon, Nancy P., Green, Beverly B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462185/ https://www.ncbi.nlm.nih.gov/pubmed/26062732 http://dx.doi.org/10.1186/s12889-015-1908-x

Ejemplares similares

Effect of Mailed Fecal Immunochemical Test Outreach for Patients Newly Eligible for Colorectal Cancer Screening
por: Burns, Shohei, et al.
Publicado: (2023)

Population Screening for Colorectal Cancer Means Getting FIT: The Past, Present, and Future of Colorectal Cancer Screening Using the Fecal Immunochemical Test for Hemoglobin (FIT)
por: Allison, James E., et al.
Publicado: (2014)

Moderators of the effectiveness of an intervention to increase colorectal cancer screening through mailed fecal immunochemical test kits: results from a pragmatic randomized trial
por: O’Connor, Elizabeth A., et al.
Publicado: (2020)

Implementation of population screening for colorectal cancer by repeated Fecal Immunochemical Test (FIT): third round
por: Stegeman, Inge, et al.
Publicado: (2012)

Feasibility and performance of the fecal immunochemical test (FIT) for average-risk colorectal cancer screening in Nigeria
por: Knapp, Gregory C., et al.
Publicado: (2021)

Is Promotion of Fecal Immunochemical Testing “FIT” to Address COVID-19 Disruptions to Colorectal Cancer Screening?
por: Trivedi, Mehul, et al.
Publicado: (2022)

Program Components and Results From an Organized Colorectal Cancer Screening Program Using Annual Fecal Immunochemical Testing
por: Selby, Kevin, et al.
Publicado: (2022)

Feasibility of Mass Screening for Colorectal Cancer Using Fecal Immunochemical Test in Iran
por: Kamangar, Farin, et al.
Publicado: (2017)

Screening for Colorectal Cancer by Immunochemical Fecal Occult Blood Testing
por: Saito, Hiroshi
Publicado: (1996)

Uptake of colorectal cancer screening after mailed fecal immunochemical test (FIT) outreach in a newly eligible 45–49-year-old community health center population
por: O’Leary, Meghan C., et al.
Publicado: (2023)

Quality Metrics of a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program in Korea
por: Kim, Dae Ho, et al.
Publicado: (2018)

Additional outreach effort of providing an opportunity to obtain a kit for fecal immunochemical test during the general health check-up to improve colorectal cancer screening rate in Japan: A longitudinal study
por: Fujita, Misuzu, et al.
Publicado: (2020)

The fecal immunochemical test (fit): Selected aspects regarding its effectiveness for colorectal cancer screening in Quebec City
por: Caron, Mireille, et al.
Publicado: (2018)

Fecal Immunochemical Tests for Colorectal Cancer Screening: Is Fecal Sampling from Multiple Sites Necessary?
por: Amitay, Efrat L., et al.
Publicado: (2019)

Correlation of Fecal Immunochemical Testing Levels With Pathology Results in a National Colorectal Cancer Screening Program
por: O'Reilly, Susanne M., et al.
Publicado: (2021)

Predictive Modeling of Colonoscopic Findings in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program
por: Law, Jade, et al.
Publicado: (2021)

Low Rates of Colonoscopy Follow-up After a Positive Fecal Immunochemical Test in a Medicaid Health Plan Delivered Mailed Colorectal Cancer Screening Program
por: Green, Beverly B., et al.
Publicado: (2020)

Effects of antithrombotic drugs on the results of fecal immunochemical test in colorectal neoplasms screening
por: Ibuka, Takashi, et al.
Publicado: (2021)

The Accuracy of Fecal Immunochemical Test in Colorectal Cancer Screening: A Meta-Analysis
por: Phuangrach, Nittaya, et al.
Publicado: (2022)

Health plan adaptations to a mailed outreach program for colorectal cancer screening among Medicaid and Medicare enrollees: the BeneFIT study
por: Coronado, Gloria D., et al.
Publicado: (2020)

Improvement of Asia-Pacific colorectal screening score and evaluation of its use combined with fecal immunochemical test
por: He, Xu-xia, et al.
Publicado: (2019)

Using fecal immunochemical tubes for the analysis of the gut microbiome has the potential to improve colorectal cancer screening
por: Krigul, Kertu Liis, et al.
Publicado: (2021)

Using fecal immunochemical test values below conventional cut-off to individualize colorectal cancer screening
por: Plantener, Eva, et al.
Publicado: (2022)

Effect of Patient Portal Messaging Before Mailing Fecal Immunochemical Test Kit on Colorectal Cancer Screening Rates: A Randomized Clinical Trial
por: Goshgarian, Gregory, et al.
Publicado: (2022)

Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the One Million Taiwanese Screening Program
por: Chiu, Han-Mo, et al.
Publicado: (2015)

Missed colorectal cancers in a fecal immunochemical test-based screening program: Molecular profiling of interval carcinomas
por: van der Vlugt, Manon, et al.
Publicado: (2022)

The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut‐off level on yield of screening
por: Kooyker, Arthur I., et al.
Publicado: (2020)

The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design
por: Wisse, P. H. A., et al.
Publicado: (2022)

Diagnosis reliability of combined flexible sigmoidoscopy and fecal-immunochemical test in colorectal neoplasia screening
por: Iovanescu, Dana, et al.
Publicado: (2016)

Clinical impact of the immunochemical fecal occult blood test for colorectal cancer screening in Brazil
por: Teixeira, Cláudio R., et al.
Publicado: (2017)

Selecting a Cut-off for Colorectal Cancer Screening With a Fecal Immunochemical Test
por: Brenner, Hermann, et al.
Publicado: (2017)

Combining the Fecal Immunochemical Test with a Logistic Regression Model for Screening Colorectal Neoplasia
por: Liu, Feiyuan, et al.
Publicado: (2021)

Adherence to fecal immunochemical test screening among adults at average risk for colorectal cancer
por: Fisher, Deborah A., et al.
Publicado: (2021)

Cost-effectiveness analysis of colonoscopy and fecal immunochemical testing for colorectal cancer screening in China
por: Ren, Yinan, et al.
Publicado: (2022)

Colorectal cancer risk after removal of polyps in fecal immunochemical test based screening
por: van Toledo, D.E.F.W.M., et al.
Publicado: (2023)

Accuracy of H. pylori fecal antigen test using fecal immunochemical test (FIT)
por: Nieuwenburg, S. A. V., et al.
Publicado: (2021)

Colorectal cancer after negative colonoscopy in fecal immunochemical test-positive participants from a colorectal cancer screening program
por: Rivero-Sánchez, Liseth, et al.
Publicado: (2018)

New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population
por: Malagón, Marta, et al.
Publicado: (2020)

A Pilot Study for Using Fecal Immunochemical Testing to Increase Colorectal Cancer Screening in Appalachia, 2008-2009
por: Kluhsman, Brenda C., et al.
Publicado: (2012)

Colonoscopy-related complications in a nationwide immunochemical fecal occult blood test-based colorectal cancer screening program
por: Mikkelsen, Ellen M, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_b0dfrrl06savkvvh4tggl1fif5